File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1201/9781315152110
- Scopus: eid_2-s2.0-85056686855
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Book Chapter: Adefovir dipivoxil
| Title | Adefovir dipivoxil |
|---|---|
| Authors | |
| Issue Date | 2018 |
| Publisher | CRC Press |
| Citation | Adefovir dipivoxil. In Grayson, ML (Editor-in-chief), Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs (7th ed.), v. 3, p. 4335-4344. Boca Raton, FL: CRC Press, 2018 How to Cite? |
| Abstract | Adefovir dipivoxil, 9-[2[[bis[(pivaloyloxy)-methoxy]phosphinyl]- methoxy]ethyl] adenine, also known as bis(POM)- PMEA, and PMEA-9-2-phosphonylmethoxyethyl-adenine, is the oral diester prodrug of adefovir, an acyclic nucleotide analog of deoxyadenosine monophosphate (Dando and Plosker, 2003). Adefovir dipivoxil is rapidly converted to adefovir in the gastrointestinal tract and then further sequentially phosphorylated intracellularly by cellular kinases to its active metabolite, adefovir diphosphate. © 2018 by Taylor & Francis Group, LLC. |
| Description | Section 5 - part 5.3 - chapter 255 |
| Persistent Identifier | http://hdl.handle.net/10722/246905 |
| ISBN |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Seto, WKW | - |
| dc.contributor.author | Lai, CL | - |
| dc.contributor.author | Yuen, RMF | - |
| dc.date.accessioned | 2017-10-18T08:19:11Z | - |
| dc.date.available | 2017-10-18T08:19:11Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Adefovir dipivoxil. In Grayson, ML (Editor-in-chief), Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs (7th ed.), v. 3, p. 4335-4344. Boca Raton, FL: CRC Press, 2018 | - |
| dc.identifier.isbn | 9781498747950 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/246905 | - |
| dc.description | Section 5 - part 5.3 - chapter 255 | - |
| dc.description.abstract | Adefovir dipivoxil, 9-[2[[bis[(pivaloyloxy)-methoxy]phosphinyl]- methoxy]ethyl] adenine, also known as bis(POM)- PMEA, and PMEA-9-2-phosphonylmethoxyethyl-adenine, is the oral diester prodrug of adefovir, an acyclic nucleotide analog of deoxyadenosine monophosphate (Dando and Plosker, 2003). Adefovir dipivoxil is rapidly converted to adefovir in the gastrointestinal tract and then further sequentially phosphorylated intracellularly by cellular kinases to its active metabolite, adefovir diphosphate. © 2018 by Taylor & Francis Group, LLC. | - |
| dc.language | eng | - |
| dc.publisher | CRC Press | - |
| dc.relation.ispartof | Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs (7th ed.) | - |
| dc.title | Adefovir dipivoxil | - |
| dc.type | Book_Chapter | - |
| dc.identifier.email | Seto, WKW: wkseto@hku.hk | - |
| dc.identifier.email | Lai, CL: hrmelcl@hkucc.hku.hk | - |
| dc.identifier.email | Yuen, RMF: mfyuen@hku.hk | - |
| dc.identifier.authority | Seto, WKW=rp01659 | - |
| dc.identifier.authority | Lai, CL=rp00314 | - |
| dc.identifier.authority | Yuen, RMF=rp00479 | - |
| dc.identifier.doi | 10.1201/9781315152110 | - |
| dc.identifier.scopus | eid_2-s2.0-85056686855 | - |
| dc.identifier.hkuros | 280081 | - |
| dc.identifier.volume | 3 | - |
| dc.identifier.spage | 4335 | - |
| dc.identifier.epage | 4344 | - |
| dc.publisher.place | Boca Raton, FL | - |